China Pharmaceutical Innovation and Research Development Association (PhIRDA), also known as 中国医药创新促进会, is a non-profit national social organization established in 1988. As a 4A-level organization registered with the Ministry of Civil Affairs, PhIRDA is committed to promoting innovation and development in the pharmaceutical industry. They serve as a platform that brings together pharmaceutical research and development companies, scientific institutions, clinical research organizations, innovation service providers, and pharmaceutical investment institutions.

With a membership of 186 units, China Pharmaceutical Innovation and Research Development Association is dedicated to promoting innovation in the pharmaceutical industry. They have established various committees and research groups covering areas such as drug development, clinical trials, pharmaceutical policy, investment, and digitalization. PhIRDA also actively engages in international collaborations through partnerships with industry associations, enterprises, research institutions, and foreign embassies, further expanding opportunities for international exchange.

The association’s work includes conducting policy research, organizing forums, conferences, and events for knowledge exchange and innovation, and facilitating international cooperation in the pharmaceutical industry. They also provide services such as information collection, evaluation, and publication to their members. China Pharmaceutical Innovation and Research Development Association plays a significant role in China's healthcare industry, contributing to the country's economic and social development as well as the improvement of public health.